Idexx Laboratories Inc - Company Profile
Powered by 
All the sales intelligence you need on Idexx Laboratories Inc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Idexx Laboratories Inc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Idexx Laboratories Inc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Related keylists
Idexx Laboratories Inc (IDEXX) is a medical devices company. The company focuses on developing, manufacturing, and distributing products and services for the companion animal veterinary, poultry and livestock, dairy, and water testing markets. The company offers point-of-care veterinary diagnostic products, laboratory diagnostic instruments, rapid assay test kits, veterinary reference laboratory diagnostics and consulting services, microbiological contaminant testing products, livestock and poultry diagnostic and health-monitoring products, and practice management, and diagnostic imaging systems and services. The company products cater to companion animal veterinary; livestock, poultry and dairy; and water testing industries. IDEXX also markets point-of-care electrolytes and blood gas analyzers for the human point-of-care medical diagnostics market. It distributes products directly and through a network of distributors and resellers across the world. IDEXX is headquartered in Westbrook, Maine, the US.
Headquarters
United States of America
Address
One Idexx Drive, Westbrook, Maine, 04092-2041
Website
www.idexx.com
Telephone
1 207 5560300
No of Employees
11,000
Industry
Medical Equipment
Ticker Symbol & Exchange
IDXX (NASD)
Revenue (2024)
$4.3B
10.4%
(2024 vs 2023)
EPS
XYZ
Net Income (2024)
XYZ
19.3%
(2024 vs 2023)
Market Cap*
$44.1B
Net Profit Margin (2024)
XYZ
8.1%
(2024 vs 2023)
* As of and is in US$
Idexx Laboratories Inc premium industry data and analytics
Products and Services
| Products | Services | Brands |
|---|---|---|
| Reference Laboratories: | Consulting Services | Animana |
| IDEXX SDMA Testing | Telemedicine | Catalyst Dx |
| Fecal Dx antigen Testing | Radiology Services | Catalyst One |
| XYZ | XYZ | XYZ |
| XYZ | XYZ | XYZ |
| XYZ | XYZ | XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2026 | New Products/Services | In April, the company launched the IDEXX Cancer Dx Panel in the UK. |
| 2026 | New Products/Services | In January, the company launched its ImageVue DR50 Plus digital radiography system. |
| 2025 | New Products/Services | In January, the company announced the launch of IDEXX Cancer Dx, a diagnostic panel with early detection of lymphoma in dogs. |
Competitor Comparison
| Key Parameters | Idexx Laboratories Inc | Thermo Fisher Scientific Inc | Fujifilm Holdings Corp | Zoetis Inc | Neogen Corp |
|---|---|---|---|---|---|
| Headquarters | United States of America | United States of America | Japan | United States of America | United States of America |
| City | Westbrook | Waltham | Minato-Ku | Parsippany | Lansing |
| State/Province | Maine | Massachusetts | Tokyo | New Jersey | Michigan |
| No. of Employees | 11,000 | 125,000 | 72,593 | 14,500 | 2,974 |
| Entity Type | Public | Public | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Jonathan J. Mazelsky | Chairman | Executive Board | 2026 | 65 |
| Michael G. Erickson | President; Chief Executive Officer; Director | Executive Board | 2026 | 52 |
| Andrew Emerson | Executive Vice President; Chief Financial Officer; Treasurer | Senior Management | 2025 | 43 |
| Jason W. Johnson | Chief Medical Officer; Senior Vice President | Senior Management | 2026 | - |
| Amit Gupta | Chief Digital & Information Officer; Senior Vice President | Senior Management | 2025 | - |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer